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The aim of this study is to develop a specific, sensitive, rapid, and simple HPLC method with UV detection to 
study pharmacokinetics of tirofiban in serum of rats alone or in the presence of heparin as simultaneous therapy. 
Thirty six Wistar rats were used randomly assigned in two groups: control group (n = 18), and group with 
venous thrombosis experimentally induced by ligature of the femoral vein (n = 18). Tirofiban hydrochloride was 
dissolved in sterile saline. The i.v. bolus doses (0.6 mg kg
-1
; 0.8 mg kg
-1
; 1 mg kg
-1
) were injected using tail 
vein. Blood samples were taken in the presence of heparin during one hour: starting 15 minutes after injection in 
the intervals of 15 minutes. Tirofiban concentration was analysed immediately. Blood samples were centrifuged 
5 min at 3500 rpm min
-1
. The serum was treated carefully, then methanol was added for precipitation of proteins 
(in ratio serum: methanol = 1:3). The tubes were again centrifuged 5 min at 3500 rpm min
-1
 and supernatant was 
injected into the HPLC column. HPLC separation was carried out at ambient temperature, using reversed-phase 
LiChrospher
®
 100 RP-18 column (4.0 mm × 250 mm, 5 μm particle size). The chromatographic separation was 
performed by isocratic mode with of 0,1 M KH2PO4 (pH = 5.0, adjusted with 1.0 N sodium hydroxide) and 
acetonitrile in the ratio of 80:20 % v/v as mobile phase with a flow rate of 1.0 ml min
-1
. UV detection was 
performed at 274 nm. The injection volume was 50 µl. Tirofiban concentration was also determined in spiked 
human and rat serum samples. System suitability was checked by evaluating different parameters (retention 
time, tailing factor, capacity factor, resolution, and selectivity). Tailing and capacity factors were obtained as 
1.17 and 2.41 for tirofiban. Resolution factor for the system for tirofiban and heparin was 3.90. The retention 
times of tirofiban in methanol, human and rat serum samples were 9.1, 9.2, and 9.16 min, respectively (Figure 
1.). The variation in retention time of tirofiban among five replicate injections of standard solution in methanol, 
human and rat serum samples was very little, giving relative standard deviations (RSD%) of  0.61%, 0.93%, and 
0.82%, respectively.  The response was linear over the range of 0.03 – 0.18 mg mL-1 in mobile phase and serum 
samples. The limit of detection (LOD) for tirofiban was 1.84, 13,8 and 14.6 μg mL-1 in methanol, spiked rat 
serum and spiked human serum, respectively (Table 1.). Plasma concentration-time profile obtained from the 
experimental group was significantly different from plasma concentration-time profile obtained from the control 
group. The proposed RP-HPLC method is simple, accurate, precise, and rapid for the determination of tirofiban 
in serum and for monitoring its concentration in serum. The described method can be readily applied, without 
any interference from endogenous substances, to study pharmacokinetics of tirofiban in serum given alone or in 
the presence of heparin as simultaneous therapy and for therapeutic monitoring of levels of tirofiban in serum 
samples. 
 
 
Table 1.  Characteristics of the linear regression analysis 
of tirofiban 
        
 
 
 
Figure 1. Chromatogram of standard solution of  
tirofiban and heparin in methanol (a) and 
chromatogram of serum spiked with tirofiban and 
heparin (b) 
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